A Phase 2 randomized clinical trial published in the prestigious JAMA found that a single dose of psilocybin (accompanied by psychotherapy) resulted in a rapid, robust and sustained reduction in depressive symptoms for people with major depressive disorder. Earlier studies have suggested that psilocybin may be a promising treatment for depression for people for whom antidepressants and therapy haven’t proven effective, but those studies focused…
![](https://globalwellnessinstitute.org/wp-content/uploads/2023/09/Brief_Featured_wellness.jpg)